Impact of impurity on kinetic estimates from transport and inhibition studies

Journal of Pharmacology and Experimental Therapeutics

Volumn 326, Issue 1, 2008, Pages 296-305

  González, Pablo ^a,b   Polli, James E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; TAUROLITHOCHOLIC ACID; URSODEOXYCHOLIC ACID;

ANIMAL CELL; ARTICLE; CELL CULTURE; DRUG BINDING; DRUG BINDING AND TRANSPORT; DRUG CONTAMINATION; DRUG IMPURITY; DRUG INHIBITION; DRUG POTENCY; DRUG TRANSPORT; DRUG UPTAKE; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RADIOASSAY; STRUCTURE ACTIVITY RELATION;

ANIMALS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; CELL LINE; COMPUTER SIMULATION; DOGS; DRUG CONTAMINATION; INTESTINAL MUCOSA; KINETICS; PHARMACEUTICAL PREPARATIONS; RESEARCH DESIGN;

EID: 45749100431     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.135863     Document Type: Article

References (12)

1. Balakrishnan A, Hussainzada N, Gonzalez P, Bermejo M, Swaan PW, and Polli JE (2007) Bias in estimation of transporter kinetic parameters from overexpression systems: interplay of transporter expression level and substrate affinity. J Pharmacol Exp Ther 320:133-144.
2. Balakrishnan A and Polli JE (2006) Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target. Mol Pharm 3:223-230.
3. Balakrishnan A, Sussman DJ, and Polli JE (2005) Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT). Pharm Res 22:1269-1280.
4. Balakrishnan A, Wring SA, Coop A, and Polli JE (2006a) Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter. Mol Pharm 3:282-292.
5. Balakrishnan A, Wring SA, and Polli JE (2006b) Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation. Pharm Res 23:1451-1459.
6. Buchwald H, Williams SE, Matts JP, and Boen JR (2002) Lipid modulation and liver function tests. A report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). J Cardiovasc Risk 9:83-87.
7. Copeland RA (2000) Enzymes: a Practical Introduction to Structure, Mechanism, and Data Analysis. John Wiley & Sons, New York.
8. Hagenbuch B and Dawson P (2004) The sodium bile salt cotransport family SLC10. Pflugers Arch 447:566-570.
9. Hofmann AF (1999) The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 159:2647-2658.
10. 2+ ions. J Lipid Res 33:617-626.
11. Sievänen E (2007) Exploitation of bile acid transport systems in prodrug design. Molecules 12:1859-1889.
12. Tolle-Sander S, Lentz KA, Maeda DY, Coop A, and Polli JE (2004) Increased acyclovir oral bioavailability via a bile acid conjugate. Mol Pharm 1:40-48.